These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6707221

  • 1. Splenic siderosis and parenteral iron dextran in maintenance haemodialysis patients.
    Murray JA, Slater DN, Parsons MA, Fox M, Smith S, Platts MM.
    J Clin Pathol; 1984 Jan; 37(1):59-64. PubMed ID: 6707221
    [Abstract] [Full Text] [Related]

  • 2. Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy.
    Ali M, Rigolosi R, Fayemi AO, Braun EV, Frascino J, Singer R.
    Lancet; 1982 Mar 20; 1(8273):652-5. PubMed ID: 6121967
    [Abstract] [Full Text] [Related]

  • 3. Haemoglobin and serum iron responses to periodic intravenous iron-dextran infusions during maintenance haemodialysis.
    Stewart WK, Fleming LW, Shepherd AM.
    Nephron; 1976 Mar 20; 17(2):121-9. PubMed ID: 940618
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ.
    Am J Nephrol; 2000 Mar 20; 20(6):455-62. PubMed ID: 11146312
    [Abstract] [Full Text] [Related]

  • 6. Consequences of parenteral iron-dextran loading investigated in minipigs. A new model of transfusional iron overload.
    Jensen PD, Nielsen AH, Simonsen CW, Baandrup UT, Vyberg M, Jensen SE, Magnusdottir SO, Krarup HB, Nielsen MF, Kjaergaard B.
    Blood Cells Mol Dis; 2020 Jul 20; 83():102440. PubMed ID: 32353700
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized cross-over study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients.
    St Peter WL, Lambrecht LJ, Macres M.
    Am J Kidney Dis; 1996 Oct 20; 28(4):523-8. PubMed ID: 8840941
    [Abstract] [Full Text] [Related]

  • 9. Parenteral iron dextran therapy: a review.
    Burns DL, Mascioli EA, Bistrian BR.
    Nutrition; 1995 Oct 20; 11(2):163-8. PubMed ID: 7647482
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
    Michael B, Coyne DW, Fishbane S, Folkert V, Lynn R, Nissenson AR, Agarwal R, Eschbach JW, Fadem SZ, Trout JR, Strobos J, Warnock DG, Ferrlecit Publication Committee.
    Kidney Int; 2002 May 20; 61(5):1830-9. PubMed ID: 11967034
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety aspects of parenteral iron in patients with end-stage renal disease.
    Sunder-Plassmann G, Hörl WH.
    Drug Saf; 1997 Oct 20; 17(4):241-50. PubMed ID: 9352960
    [Abstract] [Full Text] [Related]

  • 19. Experimental hepatic cirrhosis in dogs caused by chronic massive iron overload.
    Lisboa PE.
    Gut; 1971 May 20; 12(5):363-8. PubMed ID: 5112171
    [Abstract] [Full Text] [Related]

  • 20. Effect of intravenous iron on insulin sensitivity in dialysis patients.
    Iliescu EA, White CA, Toffelmire EB, Hudson RW.
    Hemodial Int; 2007 Oct 20; 11(4):492-3. PubMed ID: 17922749
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.